tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with trinitrobenzenesulfonic acid in 1 studies
| Studies (tyrosyl-arginyl-phenylalanyl-lysinamide) | Trials (tyrosyl-arginyl-phenylalanyl-lysinamide) | Recent Studies (post-2010) (tyrosyl-arginyl-phenylalanyl-lysinamide) | Studies (trinitrobenzenesulfonic acid) | Trials (trinitrobenzenesulfonic acid) | Recent Studies (post-2010) (trinitrobenzenesulfonic acid) |
|---|---|---|---|---|---|
| 74 | 0 | 17 | 2,710 | 10 | 1,042 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brun, V; Chuoï-Mariot, MT; Colombel, JF; Desreumaux, P; Dubuquoy, L; Gaveriaux-Ruff, C; Groux, H; Kieffer, BL; Philippe, D | 1 |
1 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and trinitrobenzenesulfonic acid
| Article | Year |
|---|---|
Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; CD4-Positive T-Lymphocytes; Colitis; Colon; Cytokines; Disease Models, Animal; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, SCID; Naloxone; Narcotic Antagonists; Oligopeptides; Peroxidase; Receptors, Opioid, mu; Trinitrobenzenesulfonic Acid | 2003 |